Kopp Investment Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Kopp Investment Advisors’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,222	Closed	-$249K	–	69
2017 Q4	$249K	Sell	10,222 -1,652	-14%	-$31.8K	0.25%	58
2017 Q3	$219K	Hold	11,874	–	–	0.2%	60
2017 Q2	$197K	Buy	11,874 +55	+0.5%	+$765	0.18%	60
2017 Q1	$163K	Buy	+11,819	New	+$190K	0.16%	59
2016 Q4	–	Sell	-10,853	Closed	-$241K	–	67
2016 Q3	$241K	Sell	10,853 -925	-8%	-$17.4K	0.24%	58
2016 Q2	$215K	Sell	11,778 -625	-5%	-$10.8K	0.11%	59
2016 Q1	$226K	Buy	+12,403	New	+$201K	0.12%	59

Kopp Investment Advisors's ENTL Position: Q1 2018 in Review

Kopp Investment Advisors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 10,222 shares — an estimated $249K sold.

Kopp Investment Advisors first reported a position in ENTL in Q1 2016 and held it in 7 quarters. The position peaked at $249K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Kopp Investment Advisors reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Kopp Investment Advisors sold 10,222 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $249K.
Kopp Investment Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2016 and held it in 7 quarters.
Kopp Investment Advisors's Entellus Medical, Inc. Common Stock position peaked at $249K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Kopp Investment Advisors's 13F filing for Q1 2018, filed 14 May 2018.